RecruitingNot ApplicableNCT06323889

Longitudinal Monitoring During Intermittent Fasting Protocols in Obese Adults

Longitudinal Monitoring During Different Intermittent Fasting Protocols in Obese Adults - a Randomized Clinical Trial


Sponsor

University of Zurich

Enrollment

90 participants

Start Date

Sep 23, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

LIMITFOOD2 is a randomized clinical intervention study that investigates the effects of two different intermittent fasting protocols compared to a control group on the health of obese adults. A total of 90 participants will be randomized into three equally sized groups: a modified alternate day fasting, a time-restricted eating and a control group, receiving general weight-loss counseling.


Eligibility

Min Age: 18 YearsMax Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called Modified Alternate Day Fasting, a behavioral approach called Time-Restricted Eating, and others for people with intermittent fasting, obesity, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 50 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALModified Alternate Day Fasting

Participants are instructed to fast every other day.

BEHAVIORALTime-Restricted Eating

Participants are instructed to limit food intake to two main meals consumed in maximum 8 hours per day

BEHAVIORALWeight-loss counseling

Participants will receive nutrition counseling to structure their main meals according to the plate model for weight-loss and to reduce number of consumed plates.


Locations(1)

Department of Endocrinology, Diabetology and Clinical Nutrition

Zurich, Canton of Zurich, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06323889


Related Trials